Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Traditional freedom-to-operate analysis is no longer an adequate risk management tool due to the pace and complexity of pharmaceutical advancements. • Artificial intelligence-assisted inventions often challenge conventional assumptions about how inventions are described and claimed. • Broadening the scope of analyses, accounting for jurisdiction-specific realities, and collaborating across functions are crucial to successful FTO programs.
By Sanandan Malhotra ( January 23, 2026, 5:54 PM EST) -- Artificial intelligence is no longer an emerging tool in drug discovery; it is now a core driver of innovation, particularly in biologics, peptides and metabolic disease therapeutics.... Law360 is on it, so you are, too. A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence.
Avian leukosis virus (ALV) is a simple retrovirus that causes a wide range of tumors in chickens, the most common of which are B-cell lymphomas. The viral genome integrates into the host genome and uses its strong promoter and enhancer sequences to alter the expression of nearby genes, frequently inducing tumors. In this study, we compare the preferences for ALV integration sites in cultured cells and in tumors, by analysis of over 87,000 unique integration sites.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
